Evolution of Surgical Management of Colorectal Liver Metastasis
- 6 March 2020
- journal article
- review article
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 04 (01) , 040-045
Abstract
The treatment of colorectal liver metastasis (CRLM) has progressed markedly in the past decades. Main contributions stem from improvement in surgical approach and applications of chemotherapy. The availability of several perioperative and surgical techniques, including portal vein embolization, ablation techniques, and two-stage hepatectomies, has expanded surgical indications. In addition, preoperative imaging methods have contributed to these advances.In patients with high oncological risk of recurrence, or initially unresectable CRLM, highly individualized treatment regimens are becoming more widely utilized. These patients should be evaluated for surgical resection after several cycles of chemotherapy given the survival benefit afforded by liver resection for CRLM. Several biomarkers, including RAS mutation, BRAF mutation, and microsatellite stability, have become essential in guiding therapy. Immunotherapy has recently been highlighted, especially for cases of microsatellite instability. Looking forward, biomarkers will likely to continue to guide individualized treatment patterns.Liver transplantation as an option for patients with unresectable CRLM may boast comparable outcomes to patients with primary liver tumors, but it remains controversial considering the limited supply of donor livers.Management of CRLM requires the complex decision making process common to contemporary tumor board discussions, and a multidisciplinary approach likely figures into future directions of management for CRLM.Keywords
This publication has 54 references indexed in Scilit:
- Centralization of liver cancer surgery and impact on multidisciplinary teams working on stage IV colorectal cancerOncology Reviews, 2017
- Population-based study on resection rates and survival in patients with colorectal liver metastasis in NorwayBritish Journal of Surgery, 2017
- Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensusCancer Treatment Reviews, 2015
- Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trialThe Lancet Oncology, 2013
- Colorectal Liver MetastasesJournal of Gastrointestinal Surgery, 2013
- Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancerColorectal Disease, 2009
- A 10-year study of outcome following hepatic resection for colorectal liver metastases – The effect of evaluation in a multidisciplinary team settingEuropean Journal of Surgical Oncology, 2009
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus StatementAnnals of Surgical Oncology, 2006
- Determinants of survival in liver resection for colorectal secondariesBritish Journal of Surgery, 1986